UBS Group AG - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 73 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$18,308
-29.9%
8,284
-19.4%
0.00%
Q1 2023$26,101
+10176.0%
10,276
+7455.9%
0.00%
Q4 2022$254
-91.5%
136
-88.5%
0.00%
Q3 2022$3,000
-50.0%
1,180
-64.2%
0.00%
Q2 2022$6,000
-14.3%
3,296
+34.1%
0.00%
Q1 2022$7,000
-90.5%
2,457
-84.9%
0.00%
Q4 2021$74,000
+516.7%
16,280
+525.9%
0.00%
Q3 2021$12,000
-7.7%
2,601
+31.0%
0.00%
Q2 2021$13,000
-59.4%
1,985
-56.2%
0.00%
Q1 2021$32,000
-31.9%
4,529
-39.9%
0.00%
Q4 2020$47,000
+487.5%
7,538
+413.1%
0.00%
Q3 2020$8,000
-88.4%
1,469
-88.8%
0.00%
Q2 2020$69,000
+13.1%
13,127
-31.8%
0.00%
Q1 2020$61,000
-62.8%
19,254
-52.8%
0.00%
Q4 2019$164,000
+92.9%
40,791
+107.0%
0.00%
Q3 2019$85,000
+962.5%
19,703
+1213.5%
0.00%
Q1 2019$8,000
-50.0%
1,500
-50.6%
0.00%
Q4 2018$16,000
-55.6%
3,037
-13.2%
0.00%
Q2 2018$36,000
+44.0%
3,500
+80.4%
0.00%
Q1 2018$25,000
-55.4%
1,940
-37.1%
0.00%
Q4 2017$56,000
-52.1%
3,085
-34.0%
0.00%
Q3 2017$117,000
-92.1%
4,671
-92.4%
0.00%
-100.0%
Q2 2017$1,483,000
-78.0%
61,526
-82.5%
0.00%
-75.0%
Q1 2017$6,750,000
+337400.0%
350,600
+211104.8%
0.00%
Q3 2016$2,0000.0%1660.0%0.00%
Q2 2016$2,000
-33.3%
1660.0%0.00%
Q1 2016$3,0000.0%1660.0%0.00%
Q4 2015$3,000
-84.2%
166
-83.5%
0.00%
Q3 2015$19,000
-60.4%
1,006
-46.1%
0.00%
Q2 2015$48,000
+77.8%
1,866
+119.3%
0.00%
Q1 2015$27,000
-51.8%
851
-42.0%
0.00%
Q4 2014$56,0001,4670.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders